Analysed DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) News Sources
CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development
10-03-2026
yahoo.com
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
18-03-2026
yahoo.com
DWTX: 143 Patients Enrolled in Phase 2b Trial of Halneuron®; Results Expected in 3Q26
23-03-2026
yahoo.com
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
15-04-2026
yahoo.com
Dogwood Therapeutics, Inc. (DWTX) Advances SP16 Program with FDA Investigational New Drug Approval
21-04-2026
yahoo.com
Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
23-04-2026
yahoo.com
Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
07-05-2026
yahoo.com
What is the current price of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)?
The current price of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) is $1.45.
DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) since the previous trading day is $-0.01.
DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) since the previous trading day is -0.6849%.
What is the most recent average sentiment score for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)?
The most recent average sentiment score for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)?
The most recent sentiment for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) is .
SEC-8K** Filing Available For DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.